Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-037231
Filing Date
2022-11-30
Accepted
2022-11-30 18:30:52
Documents
2
Period of Report
2022-11-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3655
2 EX-24 DOCUMENT attachment1.htm EX-24 4593
  Complete submission text file 0000899243-22-037231.txt   9760
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494
Business Address
Tak Paul Peter (Reporting) CIK: 0001873905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 221436623